These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32983136)

  • 1. Biogenesis of HLA Ligand Presentation in Immune Cells Upon Activation Reveals Changes in Peptide Length Preference.
    Marino F; Semilietof A; Michaux J; Pak HS; Coukos G; Müller M; Bassani-Sternberg M
    Front Immunol; 2020; 11():1981. PubMed ID: 32983136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling features of the natural MHC class II peptidome of skin-migrated dendritic cells.
    Muixí L; Contreras V; Collado JA; Alexandre Y; Ballingall K; Bonneau M; Jaraquemada D; Schwartz-Cornil I
    Int Immunol; 2012 Jan; 24(1):59-69. PubMed ID: 22194283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.
    Marcu A; Bichmann L; Kuchenbecker L; Kowalewski DJ; Freudenmann LK; Backert L; Mühlenbruch L; Szolek A; Lübke M; Wagner P; Engler T; Matovina S; Wang J; Hauri-Hohl M; Martin R; Kapolou K; Walz JS; Velz J; Moch H; Regli L; Silginer M; Weller M; Löffler MW; Erhard F; Schlosser A; Kohlbacher O; Stevanović S; Rammensee HG; Neidert MC
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of peptide presentation by dendritic cells compared with other cell types: implications for cross-priming.
    Zehn D; Cohen CJ; Reiter Y; Walden P
    Int Immunol; 2006 Dec; 18(12):1647-54. PubMed ID: 17035346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
    Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
    Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells.
    Sioud M; Skorstad G; Mobergslien A; Sæbøe-Larssen S
    FASEB J; 2013 Aug; 27(8):3272-83. PubMed ID: 23671272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen delivery.
    Robson NC; McAlpine T; Knights AJ; Schnurr M; Shin A; Chen W; Maraskovsky E; Cebon J
    Blood; 2010 Jul; 116(2):218-25. PubMed ID: 20430956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini.
    Kowalewski DJ; Walz S; Backert L; Schuster H; Kohlbacher O; Weisel K; Rittig SM; Kanz L; Salih HR; Rammensee HG; Stevanović S; Stickel JS
    Blood Cancer J; 2016 Apr; 6(4):e411. PubMed ID: 27058226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation.
    Steinman RM
    Mt Sinai J Med; 2001 May; 68(3):160-6. PubMed ID: 11373688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing Signal From Noise in Immunopeptidome Studies of Limiting-Abundance Biological Samples: Peptides Presented by I-A
    Nanaware PP; Jurewicz MM; Clement CC; Lu L; Santambrogio L; Stern LJ
    Front Immunol; 2021; 12():658601. PubMed ID: 33995376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited promiscuity of HLA-DRB1 presented peptides derived of blood coagulation factor VIII.
    van Haren SD; Wroblewska A; Herczenik E; Kaijen PH; Ruminska A; ten Brinke A; Meijer AB; Voorberg J
    PLoS One; 2013; 8(11):e80239. PubMed ID: 24244658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the exogenous antigen loading of monocyte-derived dendritic cells.
    Dieckmann D; Schultz ES; Ring B; Chames P; Held G; Hoogenboom HR; Schuler G
    Int Immunol; 2005 May; 17(5):621-35. PubMed ID: 15824067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different antigen-processing activities in dendritic cells, macrophages, and monocytes lead to uneven production of HIV epitopes and affect CTL recognition.
    Dinter J; Gourdain P; Lai NY; Duong E; Bracho-Sanchez E; Rucevic M; Liebesny PH; Xu Y; Shimada M; Ghebremichael M; Kavanagh DG; Le Gall S
    J Immunol; 2014 Nov; 193(9):4322-4334. PubMed ID: 25230751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFNγ Modulates the Immunopeptidome of Triple Negative Breast Cancer Cells by Enhancing and Diversifying Antigen Processing and Presentation.
    Goncalves G; Mullan KA; Duscharla D; Ayala R; Croft NP; Faridi P; Purcell AW
    Front Immunol; 2021; 12():645770. PubMed ID: 33968037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA anchor optimization of the melan-A-HLA-A2 epitope within a long peptide is required for efficient cross-priming of human tumor-reactive T cells.
    Chauvin JM; Larrieu P; Sarrabayrouse G; Prévost-Blondel A; Lengagne R; Desfrançois J; Labarrière N; Jotereau F
    J Immunol; 2012 Mar; 188(5):2102-10. PubMed ID: 22291187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen class II quantification by targeted mass spectrometry in dendritic-like cell lines and monocyte-derived dendritic cells.
    Casasola-LaMacchia A; Ritorto MS; Seward RJ; Ahyi-Amendah N; Ciarla A; Hickling TP; Neubert H
    Sci Rep; 2021 Jan; 11(1):1028. PubMed ID: 33441579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-presentation of synthetic long peptides by human dendritic cells: a process dependent on ERAD component p97/VCP but Not sec61 and/or Derlin-1.
    Ménager J; Ebstein F; Oger R; Hulin P; Nedellec S; Duverger E; Lehmann A; Kloetzel PM; Jotereau F; Guilloux Y
    PLoS One; 2014; 9(2):e89897. PubMed ID: 24587108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides.
    Toujas L; Delcros JG; Diez E; Gervois N; Semana G; Corradin G; Jotereau F
    Immunology; 1997 Aug; 91(4):635-42. PubMed ID: 9378506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.